Vascular pathobiology in chronic liver disease and cirrhosis - Current status and future directions

被引:221
|
作者
Iwakiri, Yasuko [1 ]
Shah, Vijay [2 ]
Rockey, Don C. [3 ]
机构
[1] Yale Univ Sch Med, Dept Internal Med, Sect Digest Dis, New Haven, CT USA
[2] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA
[3] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA
基金
美国国家卫生研究院;
关键词
Endothelial cell; Pericyte; Sinusoid; Pressure; Resistance; Therapy; NITRIC-OXIDE SYNTHASE; SINUSOIDAL ENDOTHELIAL-CELLS; PORTAL HYPERTENSIVE-RATS; HEPATIC STELLATE CELLS; SCANNING ELECTRON-MICROSCOPE; FIBROBLAST-GROWTH-FACTOR; FARNESOID X RECEPTOR; SMOOTH MUSCLE ACTIN; IN-VIVO; GENE-TRANSFER;
D O I
10.1016/j.jhep.2014.05.047
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Chronic liver disease is associated with remarkable alterations in the intra- and extrahepatic vasculature. Because of these changes, the fields of liver vasculature and portal hypertension have recently become closely integrated within the broader vascular biology discipline. As developments in vascular biology have evolved, a deeper understanding of vascular processes has led to a better understanding of the mechanisms of the dynamic vascular changes associated with portal hypertension and chronic liver disease. In this context, hepatic vascular cells, such as sinusoidal endothelial cells and pericyte-like hepatic stellate cells, are closely associated with one another, where they have paracrine and autocrine effects on each other and themselves. These cells play important roles in the pathogenesis of liver fibrosis/cirrhosis and portal hypertension. Further, a variety of signaling pathways have recently come to light. These include growth factor pathways involving cytokines such as transforming growth factor beta, platelet derived growth factor, and others as well as a variety of vasoactive peptides and other molecules. An early and consistent feature of liver injury is the development of an increase in intra-hepatic resistance; this is associated with changes in hepatic vascular cells and their signaling pathway that cause portal hypertension. A critical concept is that this process aggregates signals to the extrahepatic circulation, causing derangement in this system's cells and signaling pathways, which ultimately leads to the collateral vessel formation and arterial vasodilation in the splanchnic and systemic circulation, which by virtue of the hydraulic derivation of Ohm's law (pressure = resistance x flow), worsens portal hypertension. This review provides a detailed review of the current status and future direction of the basic biology of portal hypertension with a focus on the physiology, pathophysiology, and signaling of cells within the liver, as well as those in the mesenteric vascular circulation. Translational implications of recent research and the future directions that it points to are also highlighted. (C) 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:912 / 924
页数:13
相关论文
共 50 条
  • [31] Application of Biodegradable and Biocompatible Nanocomposites in Electronics: Current Status and Future Directions
    Liu, Haichao
    Jian, Ranran
    Chen, Hongbo
    Tian, Xiaolong
    Sun, Changlong
    Zhu, Jing
    Yang, Zhaogang
    Sun, Jingyao
    Wang, Chuansheng
    NANOMATERIALS, 2019, 9 (07):
  • [32] NAD+ metabolism and eye diseases: current status and future directions
    Liu, Siyuan
    Zhang, Wenfang
    MOLECULAR BIOLOGY REPORTS, 2023, 50 (10) : 8653 - 8663
  • [33] Stem Cell Therapy for Tendon Regeneration: Current Status and Future Directions
    Conrad, Sabine
    Weber, Kathrin
    Walliser, Ulrich
    Geburek, Florian
    Skutella, Thomas
    TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2019, 1084 : 61 - 93
  • [34] NAD+ metabolism and eye diseases: current status and future directions
    Siyuan Liu
    Wenfang Zhang
    Molecular Biology Reports, 2023, 50 : 8653 - 8663
  • [35] Exercise Training as Therapy for Heart Failure Current Status and Future Directions
    Fleg, Jerome L.
    Cooper, Lawton S.
    Borlaug, Barry A.
    Haykowsky, Mark J.
    Kraus, William E.
    Levine, Benjamin D.
    Pfeffer, Marc A.
    Pina, Ileana L.
    Poole, David C.
    Reeves, Gordon R.
    Whellan, David J.
    Kitzman, Dalane W.
    CIRCULATION-HEART FAILURE, 2015, 8 (01) : 209 - 220
  • [36] Role of Functional MRI in Liver SBRT: Current Use and Future Directions
    Tadimalla, Sirisha
    Wang, Wei
    Haworth, Annette
    CANCERS, 2022, 14 (23)
  • [37] Endoscopic Mucosal Resection in the Management of Esophageal Neoplasia: Current Status and Future Directions
    Namasivayam, Vikneswaran
    Wang, Kenneth K.
    Prasad, Ganapathy A.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2010, 8 (09) : 743 - 754
  • [38] Current status and future directions of the use of novel immunotherapeutic agents in bladder cancer
    Lenfant, Louis
    Aminsharifi, Alireza
    Seisen, Thomas
    Roupret, Morgan
    CURRENT OPINION IN UROLOGY, 2020, 30 (03) : 428 - 440
  • [39] Current status and future directions in the development and optimization of thoracic and abdominal artificial organs
    Tatum, Robert
    Wong, Daniella
    Martins, Paulo
    Tchantchaleishvili, Vakhtang
    ARTIFICIAL ORGANS, 2023, 47 (03) : 451 - 458
  • [40] Nuclear Medicine and Molecular Imaging in Urothelial Cancer: Current Status and Future Directions
    Mcdonald, Sam
    Keane, Kevin G.
    Gauci, Richard
    Hayne, Dickon
    CANCERS, 2025, 17 (02)